noom microdose glp-1 What if you could start smaller…and still move forward? Microdosing can offer a more personalized approach to GLP-1s, using less, but with intention. Small shifts. Real impact. Tap through to learn more Noom GLP-1 Access and Transparency
Description
If you have questions about coverage or affordability, our staff is here to help you every step of the way
The list price for GLP-1s for obesity ranges from $12,000 to $16,000/year [2]
Phase 3 clinical trials, which test new treatments in larger groups of people, are particularly crucial in ensuring that a drug works as intended and has minimal side effects
Competitive Landscape of Obesity GLP-1 Market The global GLP-1 and obesity drug landscape is entering a transformative phase as patent protections for semaglutide near expiry in key markets such as India and China by 2026
D.MagrissoI
